OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
43
Results
Show all
Save search
Copy query
Show results for
Unknown
(36)
Genomics
(7)
Organisms
Homo sapiens
(7)
Repository
EGA
(7)
Publication Date
Release Date
2022
(8)
2021
(7)
2023
(5)
2020
(4)
2025
(3)
2019
(2)
2026
(1)
2024
(1)
2018
(1)
2015
(1)
2014
(1)
2002
(1)
2001
(1)
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?
Not available
S-EPMC137027
|
biostudies-literature
Cite
Coupling cognitive and brainstem dysfunction in multiple sclerosis-related chronic neuropathic limb pain.
Not available
S-EPMC9155950
|
biostudies-literature
Cite
Identification of human immunodeficiency virus type 1 subtype C Gag-, Tat-, Rev-, and Nef-specific elispot-based cytotoxic T-lymphocyte responses for AIDS vaccine design.
Not available
S-EPMC114489
|
biostudies-literature
Cite
Pediatric Injury Transfer Patterns During the COVID-19 Pandemic: An Interrupted time Series Analysis.
Not available
S-EPMC9424522
|
biostudies-literature
Cite
The COVID-19 pandemic and associated rise in pediatric firearm injuries: A multi-institutional study.
Not available
S-EPMC9001175
|
biostudies-literature
Cite
Clinical characterization of Collagen XII-related disease caused by biallelic COL12A1 variants.
Not available
S-EPMC11920742
|
biostudies-literature
Cite
Tisagenlecleucel immunogenicity in relapsed/refractory acute lymphoblastic leukemia and diffuse large B-cell lymphoma.
Not available
S-EPMC9153050
|
biostudies-literature
Cite
A Phase I/II Open-Label Study of Molibresib for the Treatment of Relapsed/Refractory Hematologic Malignancies.
Not available
S-EPMC9932578
|
biostudies-literature
Cite
Tisagenlecleucel cellular kinetics, dose, and immunogenicity in relation to clinical factors in relapsed/refractory DLBCL.
Not available
S-EPMC7013261
|
biostudies-literature
Cite
Patient-reported long-term quality of life after tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma.
Not available
S-EPMC7042998
|
biostudies-literature
Cite
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets